UOTTAIMCU
HAE icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Haemonetics HAE Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-685
Closed -$51.1K – 226
2025
Q2 		$51.1K Sell
685
-340
-33% -$22.5K 0.01% 127
2025
Q1 		$65.1K Buy
+1,025
New +$69.7K 0.01% 121

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s HAE Position: Q3 2025 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 685 shares — an estimated $51.1K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in HAE in Q1 2025 and held it in 2 quarters. The position peaked at $65.1K in Q1 2025. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 685 Haemonetics shares in Q3 2025, an estimated $51.1K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Haemonetics in Q1 2025 and held it in 2 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Haemonetics position peaked at $65.1K in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2025, filed 13 Nov 2025.